Drawing for SHIELDED-CELL & IMMUNOTHERAPY PAIRS

USPTO serial 98022841

SHIELDED-CELL & IMMUNOTHERAPY PAIRS

Reviewed by CopyMark Law Group

Reg. 7329988Status 700Registered
Filing date
Status date
Registration date
Mar 12, 2024
Examiner
HA, PAULINE T.
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SHIELDED-CELL & IMMUNOTHERAPY PAIRS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Leonard

MICHAEL J. LEONARD FOX ROTHSCHILD LLP997 LENOX DRIVE, BLDG. 3LAWRENCEVILLE, NJ 08648-2311UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for gene and cell therapyACTIVE—
042Pharmaceutical research and development services in the fields of gene therapy and cell therapy; medical and pharmaceutical research and development services, all in the fields of gene therapy and cell therapy; research services relating to pharmaceutical products for gene and cell therapy; biochemistry research services relating to cell therapy and gene therapyACTIVE—
044Gene and cell therapy medical services; medical consultant services in the fields of gene therapy and cell therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 12, 2024NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 12, 2024R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Feb 5, 2024CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Jan 31, 2024DOCKASSIGNED TO EXAMINER—
Jul 5, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 4, 2023TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jul 4, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 5, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance